Etirinotecan pegol Target-Specific Pharmacodynamic (PD) Biomarkers Measured in Circulating Tumor Cells (CTCs) from Patients in the Phase 3 BEACON Study in Patients with
%20Biomarkers%20Measured%20in%20Circulating%20Tumor%20Cells%20(CTCs)%20from%20Patients%20in%20the%20Phase%203%20BEACON%20Study%20in%20Patients%20with.jpg?width=270&height=350&name=108.%20Etirinotecan%20pegol%20Target-Specific%20Pharmacodynamic%20(PD)%20Biomarkers%20Measured%20in%20Circulating%20Tumor%20Cells%20(CTCs)%20from%20Patients%20in%20the%20Phase%203%20BEACON%20Study%20in%20Patients%20with.jpg)
resources center
Collected experience from groundbreaking researchers, scientists, data experts, business innovators and studies. And a convenient hub for downloading our latest service offerings from each stage of the drug development journey.
Poster
Download Poster
Poster
Download Poster
Poster
Download Poster
Poster
Download Poster
Poster
Download Poster
Poster
Download Poster
Case Study
Download Case Study
Poster
Download Poster